Demonstration program of population-based lung cancer screening in China: Rationale and study design

Thoracic Cancer

Volumn 5, Issue 3, 2014, Pages 197-203

  Zhou, Qinghua ^a   Fan, Yaguang ^a   Wu, Ning ^b   Huang, Yunchao ^c   Wang, Ying ^a   Li, Lu ^d   Liu, Jiewei ^d   Wang, Xinyun ^a   Li, Weimin ^d   Qiao, Youlin ^e  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d SICHUAN UNIVERSITY   (China)

^e CANCER HOSPITAL   (China)

Author keywords

Feasibility study; Lung cancer; Mass screening; Spiral computed tomography

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRONCHOSCOPY; BRONCHUS INJURY; CANCER SCREENING; CHINA; CONSULTATION; EARLY DIAGNOSIS; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LOW DOSE SPIRAL COMPUTED TOMOGRAPHY; LUNG CANCER; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

EID: 84895142439     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/1759-7714.12078     Document Type: Article

References (35)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. MoHotpsro C. Report of the Third National Retrospective Survey of Death Causes in China. Chinese Academy of Medical Sciences & Peking Union Medical College Press, Beijing 2008.
3. Wang MWY, Guo B etal. Status quo and issues of direct impatient cost of lung carcinoma in China. Chin Health Econ 2007; 26: 59-62. (In Chinese.)
4. Boffetta P, Agudo A, Ahrens W etal. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst 1998; 90: 1440-1450.
5. Krewski D, Lubin JH, Zielinski JM etal. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology 2005; 16: 137-145.
6. Steenland K, Loomis D, Shy C, Simonsen N. Review of occupational lung carcinogens. Am J Ind Med 1996; 29: 474-490.
7. Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS ONE 2011; 6: e17479.
8. Yao Y, Fan Y, Wu J etal. Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis. Biochem Biophys Res Commun 2012; 423: 613-619.
9. Mei CR, Luo M, Li HM, Deng WJ, Zhou QH. DNA repair gene polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Chin J Cancer Res 2011; 23: 79-91.
10. Liu X, Fan Y, Jiang Y etal. [A cohort study on risk factors of lung cancer in Yunnan tin miners]. Zhongguo Fei Ai Za Zhi 2013; 16: 184-190. (In Chinese.)
11. Gu J, Wen Y, Zhu S etal. Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis. PLoS ONE 2013; 8: e60107.
12. Wang J-B, Fan Y-G, Jiang Y etal. Attributable causes of lung cancer incidence and mortality in China. Thorac Cancer 2011; 2: 156-163.
13. Frost JK, Ball WC Jr Levin ML etal. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 1984; 130: 549-554.
14. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: the Mayo program. J Occup Med 1986; 28: 746-750.
15. Kubik A, Polák J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer 1986; 57: 2427-2437.
16. Oken MM, Hocking WG, Kvale PA etal. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011; 306: 1865-1873.
17. Yau G, Lock M, Rodrigues G. Systematic review of baseline low-dose CT lung cancer screening. Lung Cancer 2007; 58: 161-170.
18. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF etal. Survival of patients with stage I lung cancer detected on CT screening. (Published erratum appears in N Engl J Med 2008; 359: 877; N Engl J Med 2008; 358: 1875; N Engl J Med 2008; 358: 1862) N Engl J Med 2006; 355: 1763-1771.
19. National Lung Screening Trial Research Team, Aberle DR, Adams AM etal. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
20. Wender R, Fontham ET, Barrera E Jr etal. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013; 63: 107-117.
21. Jaklitsch MT, Jacobson Fl, Austin JH etal. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012; 144: 33-38.
22. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5 Suppl.): e78S-92S.
23. National Comprehensive Cancer Network. NCCN Guidelines for Patients. NCCN, 2012.
24. Barone-Adesi F, Chapman RS, Silverman DT etal. Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study. BMJ 2012; 345: e5414.
25. Ministry of Health PsRoC. Compendium of cancer prevention and control in China (for year 2004-2010). China Cancer 2004; 14: 65-68. (In Chinese.)
26. Dong Zhi-wei, Qiao You-lin. The practice and discussion of population-based cancer screening program in China. China Cancer 2009; 18: 686-689. (In Chinese.)
27. Tammemagi CM, Pinsky PF, Caporaso NE etal. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 2011; 103: 1058-1068.
28. Cassidy A, Myles JP, van Tongeren M etal. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008; 98: 270-276.
29. Nair A, Hansell DM. European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol 2011; 21: 2445-2454.
30. Bach PB, Mirkin JN, Oliver TK etal. Benefits and harms of CT screening for lung cancer: a systematic review. (Published erratum appears in JAMA 2013; 309: 2212; JAMA 2012; 308: 1324) JAMA 2012; 307: 2418-2429.
31. Reisman DN, Marquez S. Biomarkers can promote risk stratification in CT Scanning for lung cancer detection. J Clin Exp Oncol 2012; 1: 1-3.
32. Dong X, Bicheng Z, Donald D, Kui S, Goetz K, Carl F. Lung cancer screening: from imaging to biomarker. Biomarker Res 2013; 1: 4-12.
33. MacRedmond R, McVey G, Lee M etal. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax 2006; 61: 54-56.
34. Poghosyan H, Kennedy Sheldon L, Cooley ME. The impact of computed tomography screening for lung cancer on smoking behaviors: a teachable moment. Cancer Nurs 2012; 35: 446-475.
35. Field JK, Smith RA, Aberle DR etal. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol 2012; 7: 10-19.